Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | Mr. Ronald William PenczekSenior VP, Controller & CAO | -369,00 | 148,77k | Vendita | 403,16 | 1,35k | -21,50% |
| 2026-06-11 | Mr. Robert L. DixonIndependent Director | -151,00 | 60,67k | Vendita | 401,77 | 7,09k | -2,08% |
| 2026-05-19 | Mr. Ronald William PenczekSenior VP, Controller & CAO | -1,53k | 166,61k | Derivative Exercise and Sale | 271,27 - 403,13 | 1,72k | - |
| 2026-03-12 | Ms. Amy W. SchulmanIndependent Director | -26,00 | 7,48k | Vendita | 287,50 | 0,00 | -100,00% |
| 2026-03-06 | Mr. Charles Morgan KendrickEVP and President of Commercial & Specialty Health Benefits | -3,20k | 910,60k | Vendita | 284,92 | 5,16k | -38,25% |
| 2026-03-05 | Mr. Steven H. CollisIndependent Director | 3,00k | 869,52k | Acquisto | 289,84 | 3,64k | 469,48% |
| 2026-03-02 | Mr. Ronald William PenczekSenior VP, Controller & CAO | -168,00 | 49,03k | Sale to Issuer | 284,03 - 294,07 | 1,71k | -8,96% |
| 2026-03-03 | Ms. Erin M. WesslingExec. VP & Chief Legal Officer | -417,00 | 118,44k | Sale to Issuer | 284,03 | 7,58k | -5,22% |
| 2026-03-02 | Ms. Felicia Farr NorwoodExec. VP & Chief Health Benefits Officer | -1,92k | 558,75k | Sale to Issuer | 284,03 - 294,07 | 30,06k | -5,99% |
| 2026-03-02 | Mr. Ryan R. CraigExec. VP & Chief HR Officer | -334,00 | 95,12k | Sale to Issuer | 284,03 - 294,07 | 501,00 | -40,00% |
| 2026-03-02 | Mr. Peter David HaytaianSpecial Advisor | -1,65k | 479,86k | Sale to Issuer | 284,03 - 294,07 | 24,40k | -6,32% |
| 2026-03-02 | Mr. Charles Morgan KendrickEVP and President of Commercial & Specialty Health Benefits | -1,68k | 488,76k | Sale to Issuer | 284,03 - 294,07 | 8,36k | -16,72% |
| 2026-03-02 | Mr. Ratnakar V. LavuExec. VP & Chief Digital Information Officer | -537,00 | 155,69k | Sale to Issuer | 284,03 - 294,07 | 2,10k | -20,36% |
| 2026-03-02 | Ms. Gail Koziara BoudreauxPresident, CEO & Director | -8,45k | 2,47M | Sale to Issuer | 284,03 - 294,07 | 143,27k | -5,57% |
| 2026-03-02 | Mr. Mark Bradley KayeExec. VP & CFO | -624,00 | 179,96k | Sale to Issuer | 284,03 - 294,07 | 5,38k | -10,40% |
| 2026-02-02 | Mr. Ryan R. CraigExec. VP & Chief HR Officer | -279,00 | 95,37k | Sale to Issuer | 341,83 | 835,00 | -25,04% |
| 2025-10-02 | Mr. Mark Bradley KayeExec. VP & CFO | -2,90k | 984,99k | Sale to Issuer | 340,24 | 3,88k | -42,72% |
| 2025-09-03 | Ms. Erin M. WesslingExec. VP & Chief Legal Officer | -152,00 | 48,88k | Sale to Issuer | 321,59 | 5,02k | -2,94% |
| 2025-08-19 | Ms. Susan Dodson DeVoreIndependent Director | 1,20k | 374,58k | Acquisto | 312,15 | 1,20k | - |
| 2025-07-18 | Ms. Gail Koziara BoudreauxPresident, CEO & Director | 1,05k | 302,36k | Acquisto | 287,96 | 132,04k | 0,80% |
| 2025-07-18 | Ms. Gail Koziara BoudreauxPresident, CEO & Director | 7,45k | 2,14M | Acquisto | 286,07 - 287,12 | 132,04k | 5,98% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
